Absci (ABSI) Return on Capital Employed (2021 - 2026)
Absci (ABSI) reported Return on Capital Employed of 66.39% for Q1 2026, down 860.0% on a YoY basis from 8.74% in Q1 2025, and down 14.71% sequentially from 57.88% in Q4 2025.
Absci (ABSI) Return on Capital Employed (2021 - 2026) Analysis & Trends
Absci (ABSI) has 6 years of Return on Capital Employed data on file, last reported at 66.39% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed fell 860.0% year-over-year to 66.39%; the trailing twelve-month figure through Mar 2026 stood at 66.39% (down 860.0% YoY), and the FY2025 full-year result was 62.6%, down 431.0% from the prior year.
- Return on Capital Employed declined to 66.39% in Q1 2026, from 57.88% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 25.18% in Q1 2022 to a low of 66.39% in Q1 2026.
- A 5-year average of 48.18% and a median of 51.49% in 2023 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed plunged 2297 bps in 2023 and surged 572 bps in 2024, its largest moves.
- Tracing ABSI's Return on Capital Employed over 5 years: stood at 35.59% in 2022, then tumbled by 65 bps to 58.56% in 2023, then advanced by 5 bps to 55.62% in 2024, then fell by 4 bps to 57.88% in 2025, then slipped by 15 bps to 66.39% in 2026.
- Business Quant data shows ABSI's Return on Capital Employed at 66.39% in Q1 2026, 57.88% in Q4 2025, and 60.21% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - | -66.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -66.39% |
| Dec 31, 2025 | -57.88% |
| Sep 30, 2025 | -60.21% |
| Jun 30, 2025 | -62.05% |
| Mar 31, 2025 | -57.79% |
| Dec 31, 2024 | -55.62% |
| Sep 30, 2024 | -47.49% |
| Jun 30, 2024 | -40.99% |
| Mar 31, 2024 | -51.87% |
| Dec 31, 2023 | -58.56% |
| Sep 30, 2023 | -51.49% |
| Jun 30, 2023 | -46.71% |
| Mar 31, 2023 | -36.43% |
| Dec 31, 2022 | -35.59% |
| Sep 30, 2022 | -34.67% |
| Jun 30, 2022 | -30.09% |
| Mar 31, 2022 | -25.18% |
| Dec 31, 2021 | -18.63% |
| Sep 30, 2021 | -16.61% |